Trial Profile
Association between high levels of natural killer cells and tocilizumab response in patients with severe rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 10 Dec 2015 New trial record